Welcome to Newomics - Innovation Integration

Newomics Inc., an early stage biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.

 
 

Technologies



Mass spectrometry is the enabling technology for proteomics. To fully realize the enormous potential of lab-on-a-chip in proteomics.
Read More...

Products



Services



 
 

News & Events

2014.10.09

Newomics announces that it has been awarded two NIH SBIR Phase I grants totaling $1.3 million. One is from NIA to develop a new platform for early diagnosis of Alzheimer's disease, and the other is from NIAID to develop a new platform for radiation biodosimetry..
Read more...

2014.07.11

Newomics announces that Dr. Gregory Henderson and Dr. Henry Chang will join the team as Senior Scientists.
Read more...

2014.05.15

Newomics is awarded a NIGMS SBIR grant to develop a new platform for top-down proteomics, and a NCCAM SBIR grant to develop a new platform for natural products research (GenomeWeb.com news article).
Read more...